Medications
Resources
Basic InformationMore InformationLatest News
Health Tip: Packing Prescriptions for TravelDrug Errors Peak in July When New Docs StartFDA Warns Consumers Against Swallowing Topical BenadrylStudy Shows Some Anti-Seizure Meds Raise Suicide RiskPrescriptions Translated to Spanish Could Be Hazardous to HealthTougher-to-Abuse Form of OxyContin ApprovedVaccines-By-Patch Good News for Needle-PhobicRifaximin Maintains Remission in Patients With Liver DiseaseMenstrual Cramps May Be Helped by New DrugNew Inhaled Insulin Shows Promise for DiabetesPlavix Can Help Cut Death Risk in Certain Heart PatientsFDA Asks Docs to Suspend Using Glaxo Rotavirus VaccineFDA Says High-Dose Simvastatin Ups Myopathy RiskHigh-Dose Zocor Boosts Muscle Injury Risk: FDAAvandia Researchers' Financial Ties QuestionedCarbaglu Approved for Rare Genetic DisorderACC: New Dual-Acting Drug Lowers Blood PressureNewer Blood Thinner Beats Plavix for Bypass PatientsArthritis Drug May Fight Diabetes, Too2 Drugs Fail to Prevent Diabetes in the OverweightFDA Adds Boxed Warning to Clopidogrel LabelThiazolidinediones Not Linked to Diabetic Macular EdemaYoung Kids to Benefit From Broader Pneumococcal VaccineBleeding Alert Sounded for Stroke DrugsLink Between Diabetes and Neuroleptic Drugs OutlinedResistance Likely to Develop With New Hepatitis C DrugsLasofoxifene Examined in Postmenopausal WomenSuccessor to Combination Pneumococcal Vaccine ApprovedMenveo Vaccine Approved for Bacterial MeningitisFDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the MarketRituxan Approved for Chronic Lymphocytic LeukemiaNew Technology Could Widen Reach of VaccinesFDA Issues Warning on Key Asthma DrugsFDA Issues Maalox Total Relief WarningIbuprofen May Help Stave Off Parkinson'sFDA Tightens Controls on Anemia DrugsAdded Drug Aids MS Treatment'Fishy Smell' May Keep Patients From Diabetes DrugBotox May Prevent Some MigrainesAnother Study Refutes Vaccination-Autism LinkCrestor Approval ExpandedParoxetine May Compromise the Efficacy of TamoxifenNeedle Length May Affect Vaccination Results in ObeseDrug May Ease Cognitive Effects of Huntington'sGlaucoma Drugs May Play Role in Longer LifeH1N1 Vaccination Still Highly RecommendedThe Lancet Retracts Study Linking MMR Vaccine, AutismXiaflex Approved for Rare Hand ConditionAntidepressants After Stroke May Boost Mental AbilityFDA Revises Label for the HIV Drug Didanosine
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Major Depression & Unipolar Varieties
Medical Disorders
Mental Disorders
Mental Health Professions

Mail-Order Pharmacy Use May Improve Drug Adherence

HealthDay News
by -- Jane Parry
Updated: Jan 22nd 2010

new article illustration

FRIDAY, Jan. 22 (HealthDay News) -- Patients who refill prescriptions for diabetes medications by mail order have higher rates of drug adherence than their counterparts who refill at local pharmacies, according to a study in the January issue of the American Journal of Managed Care.

O. Kenrik Duru, M.D., of the David Geffen School of Medicine at the University of California in Los Angeles, and colleagues conducted a study of 13,922 patients from the Kaiser Permanente Northern California diabetes registry who refilled an antiglycemic, antihypertensive or lipid-lowering index medication prescription.

The researchers found that good adherence to their drug regimen, defined as having medication available at least 80 percent of the time, was higher among those who refilled prescriptions by mail (84.7 percent versus 76.9 percent for those who refilled at local pharmacies). The association held even after adjusting for potential confounders, such as out-of-pocket costs, the investigators note, but the practice was less prevalent among patients from ethnic minorities and lower socioeconomic groups.

"Our findings also suggest the intriguing potential of larger organization-level interventions to improve adherence by promoting increased mail-order use," the authors write. "Despite their potential benefits, interventions to increase mail-order pharmacy use would need to be carefully designed and implemented to avoid inadvertently harming patients. Such interventions should not come at the expense of face-to-face pharmacist time needed to clarify dosing schedules or check for adverse drug interactions, including dietary supplements or over-the-counter medications."

Abstract
Full Text




Family Service & Community Mental Health Center
4100 Veterans Parkway
McHenry, IL  60050 [map]

815-385-6400


powered by centersite dot net